Literature DB >> 35260788

A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits.

Qiannan Zhao1,2,3, Hengyi Cao1,4,5, Wenjing Zhang1,2,3, Siyi Li1,2,3, Yuan Xiao1,2,3, Carol A Tamminga6, Matcheri S Keshavan7, Godfrey D Pearlson8, Brett A Clementz9, Elliot S Gershon10, Scot Kristian Hill11, Sarah K Keedy10, Elena I Ivleva6, Rebekka Lencer12, John A Sweeney1,13, Qiyong Gong14,15,16, Su Lui17,18,19.   

Abstract

Some patients with schizophrenia have severe cognitive impairment and functional deficits that require long-term institutional care. The patterns of brain-behavior alterations in these individuals, and their differences from patients living successfully in the community, remain poorly understood. Previous cognition-based studies for stratifying schizophrenia patients highlight the importance of subcortical structures in the context of illness heterogeneity. In the present study, subcortical volumes from 96 institutionalized patients with long-term schizophrenia were evaluated using cluster analysis to test for heterogeneity. These data were compared to those from two groups of community-dwelling individuals with schizophrenia for comparison purposes, including 68 long-term ill and 126 first-episode individuals. A total of 290 demographically matched healthy participants were included as normative references at a 1:1 ratio for each patient sample. A subtype of institutionalized patients was identified based on their pattern of subcortical alterations. Using a machine learning algorithm developed to discriminate the two groups of institutionalized patients, all three patient samples were found to have similar rates of patients assigned to the two subtypes (approximately 50% each). In institutionalized patients, only the subtype with the identified pattern of subcortical alterations had greater neocortical and cognitive abnormalities than those in the similarity classified community-dwelling patients with long-term illness. Thus, for the subtype of patients with a distinctive pattern of subcortical alterations, when the distinct pattern of subcortical alterations is present and particularly severe, it is associated with cognitive impairments that may contribute to persistent disability and institutionalization.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Year:  2022        PMID: 35260788      PMCID: PMC9556672          DOI: 10.1038/s41386-022-01300-w

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  54 in total

Review 1.  The human hippocampus and spatial and episodic memory.

Authors:  Neil Burgess; Eleanor A Maguire; John O'Keefe
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

2.  Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study.

Authors:  Daisuke Koshiyama; Masaki Fukunaga; Naohiro Okada; Fumio Yamashita; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Kazutaka Ohi; Haruo Fujino; Yoshiyuki Watanabe; Kiyoto Kasai; Ryota Hashimoto
Journal:  Transl Psychiatry       Date:  2018-01-10       Impact factor: 6.222

3.  Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.

Authors:  S E Chua; Y Deng; E Y H Chen; C W Law; C P Y Chiu; C Cheung; J C H Wong; N Lienenkaëmper; V Cheung; J Suckling; G M McAlonan
Journal:  Psychol Med       Date:  2008-08-20       Impact factor: 7.723

4.  Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

Authors:  Brett A Clementz; John A Sweeney; Jordan P Hamm; Elena I Ivleva; Lauren E Ethridge; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

Review 5.  Sensory and cognitive functions of the basal ganglia.

Authors:  L L Brown; J S Schneider; T I Lidsky
Journal:  Curr Opin Neurobiol       Date:  1997-04       Impact factor: 6.627

6.  Basal ganglia volumetric changes in psychotic spectrum disorders.

Authors:  Cuizhen Liu; Bo Cao; Rongjun Yu; Kang Sim
Journal:  J Affect Disord       Date:  2019-05-28       Impact factor: 4.839

7.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

8.  Neuropsychological variability, symptoms, and brain imaging in chronic schizophrenia.

Authors:  Paul G Nestor; Marek Kubicki; Motoaki Nakamura; Margaret Niznikiewicz; James J Levitt; Martha E Shenton; Robert W McCarley
Journal:  Brain Imaging Behav       Date:  2013-03       Impact factor: 3.978

9.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

Authors:  Sander V Haijma; Neeltje Van Haren; Wiepke Cahn; P Cédric M P Koolschijn; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2012-10-05       Impact factor: 9.306

10.  Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

Authors:  S Kristian Hill; Daniel Schuepbach; Ellen S Herbener; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2004-05-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.